Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.6674
+0.0816 (13.93%)
At close: Aug 1, 2025, 4:00 PM
0.6850
+0.0176 (2.64%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Cognition Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
41295961139-
Upgrade
Market Cap Growth
-63.26%-50.97%-2.39%-56.29%--
Upgrade
Enterprise Value
2682715216-
Upgrade
Last Close Price
0.670.701.852.106.32-
Upgrade
PB Ratio
3.371.552.431.512.72-
Upgrade
P/TBV Ratio
3.371.552.431.512.72-
Upgrade
Debt / Equity Ratio
0.050.040.050.04--1.00
Upgrade
Quick Ratio
1.942.493.075.807.251.95
Upgrade
Current Ratio
2.092.653.376.117.502.13
Upgrade
Return on Equity (ROE)
-161.93%-157.19%-79.69%-46.76%-60.93%-
Upgrade
Return on Assets (ROA)
-107.53%-103.15%-74.08%-49.69%-53.95%-149.26%
Upgrade
Return on Capital (ROIC)
-156.66%-148.99%-94.02%-58.54%-69.67%-1506.84%
Upgrade
Earnings Yield
-80.49%-116.59%-43.40%-35.15%-8.41%-
Upgrade
FCF Yield
-75.19%-97.74%-27.20%-30.72%-2.63%-
Upgrade
Buyback Yield / Dilution
-49.90%-32.31%-27.03%-355.42%-921.60%-8.18%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q